Found 966 matching trials
A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients
NACOPERNIC is an international, multicentre, single-arm study. Chemo-refracto...
Location
Institut Jules Bordet
Immune Tumor Stroma Factors and Pathologic Complete Response After Neoadjuvant Chemotherapy in Early Breast Cancer
NAThis prospective cohort study aims to identify immune-related predictive fa...
Status
Active Not Recruiting
Location
Institute of Oncology Ljubljana
Using ctDNA to Determine Therapies for Lung Cancer
PHASE2This is a study to look at whether the presence of circulating tumour DNA (...
Location
Princess Margaret Cancer Centre
MDT-bridged Radical Therapy After Aumolertinib With MRD-guided Maintenance in EGFRm+ Unresectable Stage III NSCLC (APPROACH)
PHASE3This is an open-label, multi-center, randomized, phase III study. It is aim...
Status
Active Not Recruiting
Location
Guangdong Lung cancer institute
Personalised Disease Monitoring in Metastatic Breast Cancer
N/APatients with metastatic breast cancer may respond well to treatment and me...
Status
Active Not Recruiting
Location
Department of Oncology, Sahlgrenska University Hospital
Comparison of Whole-body MRI, Circulating DNA and PET-CT in Staging, Prognosis, and Treatment Response in Patients with Diffuse Large Cell B Lymphoma
N/AThe aim of the study is to compare the diagnostic performance of whole-body...
Location
Department of Radiology, General University Hospital in Prague, Prague, Czech Republic
ctDNA-guided First-line Immuno-de-escalation Therapy for IVB-stage and Recurrent Cervical Cancer
NAThis study aims to evaluate the clinical feasibility of first-line immunoch...
Location
The Obstetrics and Gynecology Hospital of Fudan University
Application of Polygenic Methylation Markers in Postoperative Recurrence Monitoring of Colorectal Cancer
N/AThis study dynamically monitored the prognosis of stage I-IV colorectal can...
Status
Active Not Recruiting
Location
Cancer hospital Chinese academy of medical sciences
Circulating Tumor DNA Alterations in Non-small Cell Lung Cancer Patients Treated With Pembrolizumab
N/AThe purpose of this study is to learn how to use blood tests to better pred...
Location
Columbia University Irving Medical Center
Biomarkers for Risk Stratification in Lung Cancer
N/AThis is a prospective observational study that will follow patients who und...
Location
Zuckerberg San Francisco General Hospital and Trauma Center